<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0188-2198</journal-id>
<journal-title><![CDATA[Revista mexicana de cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Mex. Cardiol]]></abbrev-journal-title>
<issn>0188-2198</issn>
<publisher>
<publisher-name><![CDATA[Asociación Nacional de Cardiólogos de México, Sociedad de Cardiología Intervencionista de México]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0188-21982017000100035</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Amphetamine-related dilatated cardiomyopathy: a growing phenomenon. Case report]]></article-title>
<article-title xml:lang="es"><![CDATA[Cardiomiopatía dilatada por consumo de anfetaminas: un fenómeno creciente. Reporte de un caso]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Solís-Olivares]]></surname>
<given-names><![CDATA[Carlos Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez-García]]></surname>
<given-names><![CDATA[Héctor Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General de Zona No. 67 ]]></institution>
<addr-line><![CDATA[Apodaca Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General de Zona No. 67 ]]></institution>
<addr-line><![CDATA[Apodaca Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2017</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>35</fpage>
<lpage>39</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0188-21982017000100035&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0188-21982017000100035&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0188-21982017000100035&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The consumption of amphetamines and its derivatives, either recreationally or for working reasons, is widespread, currently being the second most consumed drug worldwide. An often overlooked aspect of this drug has been its toxicity over the myocardium. In the following text we describe the case of a young male patient, without any relevant previous conditions, except alcohol ingestion in moderate quantity along with 3 years of using amphetamine-type stimulants and cocaine, whose main clinical manifestation was sudden onset dyspnea with minimal effort, which progressed to resting dyspnea after the ingestion of several tablets of clobenzorex, which was initially hospitalized with a diagnostic of pneumonia and finally diagnosed with a dilatated cardiomyopathy. Substance abuse should be a warning flag on patients presenting with dyspnea in order to think of a possible drug related cardiomyopathy, avoiding that way undue delays on appropriate diagnosis and treatment.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El consumo de anfetaminas y sus derivados, ya sea recreativo o por razones de trabajo, es generalizado, siendo actualmente la segunda droga más consumida en el mundo. Un aspecto a menudo pasado por alto sobre esta droga, ha sido su toxicidad sobre el miocardio. En el siguiente texto, se describe el caso de un paciente varón joven, sin condiciones previas relevantes, excepto la ingesta de alcohol en cantidad moderada junto con tres años de uso de estimulantes de tipo anfetamínico y cocaína, cuya manifestación clínica principal fue disnea de inicio repentino con esfuerzo mínimo, que evolucionó a disnea de reposo tras la ingestión de varias tabletas de clobenzorex, que inicialmente fue hospitalizado con un diagnóstico de neumonía y finalmente diagnosticado con miocardiopatía dilatada. El abuso de sustancias debe ser un indicador de advertencia en los pacientes que presentan disnea para pensar en una posible cardiomiopatía relacionada con drogas, evitando así retrasos indebidos en el diagnóstico y tratamiento adecuados.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Cardiomyopathy]]></kwd>
<kwd lng="en"><![CDATA[amphetamines]]></kwd>
<kwd lng="en"><![CDATA[methamphetamines]]></kwd>
<kwd lng="en"><![CDATA[young]]></kwd>
<kwd lng="en"><![CDATA[addiction]]></kwd>
<kwd lng="en"><![CDATA[cardiotoxicity]]></kwd>
<kwd lng="es"><![CDATA[Cardiomiopatía]]></kwd>
<kwd lng="es"><![CDATA[anfetaminas]]></kwd>
<kwd lng="es"><![CDATA[metanfetaminas]]></kwd>
<kwd lng="es"><![CDATA[jóvenes]]></kwd>
<kwd lng="es"><![CDATA[adicción]]></kwd>
<kwd lng="es"><![CDATA[cardiotoxicidad]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>United Nations Office on Drugs and Crime</collab>
<source><![CDATA[World Drug Report 2015 Chapter 1 Status and trend analysis of illicit drug markets]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villatoro-Velázquez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Medina-Mora]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Fleiz-Bautista]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Téllez-Rojo]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Alvarado]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Encuesta Nacional de Adicciones 2011: Reporte de drogas [National Addiction Poll 2011: Drug Report]]]></source>
<year>2012</year>
<page-range>71</page-range><publisher-loc><![CDATA[México D.F. (MX) ]]></publisher-loc>
<publisher-name><![CDATA[INPRFM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<collab>Comisión Nacional Contra las Adicciones (MX)</collab>
<source><![CDATA[Informe ejecutivo: I. Generalidades de los estimulantes tipo anfetamínico (énfasis en metanfetamina) [Executive summary: I. Generalities of amphetamine type stimulants (emphasis on metamphetamine)]]]></source>
<year>2013</year>
<page-range>5</page-range><publisher-loc><![CDATA[Mexico D.F. (MX) ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<collab>International Narcotics Control Board</collab>
<source><![CDATA[Report of the International Narcotics Control Board for 2015]]></source>
<year>2016</year>
<page-range>118</page-range><publisher-loc><![CDATA[New York (NY) ]]></publisher-loc>
<publisher-name><![CDATA[United Nations Publication]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico.]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brouwer]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Case]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Magis-Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bucardo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
</person-group>
<source><![CDATA[Subst Use Misuse [Internet]]]></source>
<year>2006</year>
<volume>41</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>707-27</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methamphetamine and cardiovascular pathology: a review of the evidence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaye]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McKetin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Duflou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Darke]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Addiction [Internet]]]></source>
<year>2007</year>
<volume>102</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1204-11</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methamphetamine-associated cardiomyopathy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Won]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Shohet]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
<name>
<surname><![CDATA[Seto]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Parikh]]></surname>
<given-names><![CDATA[NI]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Cardiol [Internet]]]></source>
<year>2013</year>
<volume>36</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>737-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dilated cardiomyopathy secondary to chronic cocaine abuse: a case report]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Said]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Alkhateeb]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Trien]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ajmal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[BMC Res Notes [Internet]]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>536</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[An unusual cause of breathlessness in a young man]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Innasimuthu]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Sankarnarayanan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Hornung]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol [Internet]]]></source>
<year>2009</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>369-71</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA["Ally McBeal heart?"- Drug induced cardiomyopathy in a young woman]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crean]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Pohl]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Clin Pharmacol [Internet]]]></source>
<year>2004</year>
<volume>58</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>558-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methamphetamine-induced cardiotoxicity with heart failure in a young adult: a case report and literature review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<source><![CDATA[J Emerg Crit Care Med [Internet]]]></source>
<year>2013</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>61-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Relation between alcohol intake, myocardial enzyme activity, and myocardial function in dilated cardiomyopathy. Evidence for the concept of alcohol induced heart muscle disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wodak]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Saunders]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Jewitt]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<source><![CDATA[Br Heart J [Internet]]]></source>
<year>1986</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>165-70</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Alcoholic cardiomyopathy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzzo-Merello]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cobo-Marcos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego-Delgado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Pavia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Cardiol [Internet]]]></source>
<year>2014</year>
<volume>6</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>771-81</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cardiovascular effects of cocaine]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Rezkalla]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kloner]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation [Internet]]]></source>
<year>2010</year>
<volume>122</volume>
<page-range>2558-69</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Methamphetamine and ethanol interactions in humans]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendelson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Upton]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peyton]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Pharmacol Ther [Internet]]]></source>
<year>1995</year>
<volume>57</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>559-68</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klimas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug-induced cardiomyopathies]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Veselka]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Cardiomyopathies - From basic research to clinical management [Internet]]]></source>
<year>2012</year>
<publisher-name><![CDATA[InTech]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
